MBI's media team has the skills and relationships with national and international print, online and broadcast media to get your story told.
MBI has a seasoned investor relations team and a proven track record of building or restoring credibility with investors and analysts.
MBI brings a fresh, strategic approach to business development for its clients within the biotechnology, medical device, and life sciences industries.
MBI specializes in branding and rebranding private and public life science companies. A clear and consistent corporate identity is the keystone to a successful communications plan.
Image Building | Visual Branding
MBI understands that corporate credibility is one of the most important assets a company can build and that it is one of the hardest to repair when damaged by a crisis.
There are over 1,000 life science industry conferences scheduled around the
world each year... Learn
04/23/14 - BaroFold Awarded Patent for Using High Pressure to
Improve the Safety Profile of Biologic Drugs
04/22/14 - NeuroPhage Discovers GAIM-changing Molecules to Combat
Alzheimer's Disease and Other Neurodegenerative Disorders
04/22/14 - Enanta Pharmaceuticals Announces New Drug Application
Submission to the U.S. FDA for All-Oral, Interferon-Free Hepatitis C
Regimen; Filing Triggers Milestone Payment to Enanta
Biomedical Clients in
Come and schedule meetings with our clients during the week of
January 13-16, 2014
© 2014 MacDougall Biomedical